Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516486
  • Report
  • Region: Europe
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Age-Related Macular Degeneration patients study in a new research ‘Europe Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for EU5 countries. The research measures key indicators including prevalence of Age-Related Macular Degeneration derived from epidemiological analysis, patients diagnosed with Age-Related Macular Degeneration, and patients treated with a drug therapy.

The research study helps executives estimate Age-Related Macular Degeneration market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Age-Related Macular Degeneration prevalence, Age-Related Macular Degeneration diagnosis rate, and Age-Related Macular Degeneration treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features of the Report:
  • Age-Related Macular Degeneration Patient Flow
  • Age-Related Macular Degeneration Prevalence
  • Age-Related Macular Degeneration Diagnosed Patients
  • Age-Related Macular Degeneration Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Age-Related Macular Degeneration: Disease Definition
2. Age-Related Macular Degeneration Patient Flow in Europe
2A. Age-Related Macular Degeneration Prevalence in Europe
2B. Age-Related Macular Degeneration Diagnosed Patients in Europe
2C. Age-Related Macular Degeneration Treated Patients in Europe
3. Age-Related Macular Degeneration Patient Flow in Germany
3A. Age-Related Macular Degeneration Prevalence in Germany
3B. Age-Related Macular Degeneration Diagnosed Patients in Germany
3C. Age-Related Macular Degeneration Treated Patients in Germany
4. Age-Related Macular Degeneration Patient Flow in France
4A. Age-Related Macular Degeneration Prevalence in France
4B. Age-Related Macular Degeneration Diagnosed Patients in France
4C. Age-Related Macular Degeneration Treated Patients in France
5. Age-Related Macular Degeneration Patient Flow in Spain
5A. Age-Related Macular Degeneration Prevalence in Spain
5B. Age-Related Macular Degeneration Diagnosed Patients in Spain
5C. Age-Related Macular Degeneration Treated Patients in Spain
6. Age-Related Macular Degeneration Patient Flow in Italy
6A. Age-Related Macular Degeneration Prevalence in Italy
6B. Age-Related Macular Degeneration Diagnosed Patients in Italy
6C. Age-Related Macular Degeneration Treated Patients in Italy
7. Age-Related Macular Degeneration Patient Flow in UK
7A. Age-Related Macular Degeneration Prevalence in UK
7B. Age-Related Macular Degeneration Diagnosed Patients in UK
7C. Age-Related Macular Degeneration Treated Patients in UK
8. Research Methodology

List of Tables
Table 1: Age-Related Macular Degeneration Patient Flow in Europe, 2017
Table 2: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2017 - 2026
Table 3: Age-Related Macular Degeneration Patient Flow in Germany, 2017
Table 4: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2017 - 2026
Table 5: Age-Related Macular Degeneration Patient Flow in France, 2017
Table 6: Age-Related Macular Degeneration Patient Flow Forecast in France, 2017 - 2026
Table 7: Age-Related Macular Degeneration Patient Flow in Spain, 2017
Table 8: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2017 - 2026
Table 9: Age-Related Macular Degeneration Patient Flow in Italy, 2017
Table 10: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2017 - 2026
Table 11: Age-Related Macular Degeneration Patient Flow in UK, 2017
Table 12: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2017 - 2026

List of Figures
Figures 1: Age-Related Macular Degeneration Patient Flow in Europe, 2017
Figure 2: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2017 - 2026
Figure 3: Age-Related Macular Degeneration Patient Flow in Germany, 2017
Figure 4: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2017 - 2026
Figure 5: Age-Related Macular Degeneration Patient Flow in France, 2017
Figure 6: Age-Related Macular Degeneration Patient Flow Forecast in France, 2017 - 2026
Figure 7: Age-Related Macular Degeneration Patient Flow in Spain, 2017
Figure 8: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2017 - 2026
Figure 9: Age-Related Macular Degeneration Patient Flow in Italy, 2017
Figure 10: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2017 - 2026
Figure 11: Age-Related Macular Degeneration Patient Flow in UK, 2017
Figure 12: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll